Genmab A (GMAB) EPS (Basic): 2018-2021
- Genmab A's EPS (Basic) rose 360.02% to $1.99 in Q2 2021 from the same period last year, while for Jun 2021 it was $4.24, marking a year-over-year increase of 141.94%. This contributed to the annual value of $8.48 for FY2020, which is 137.05% up from last year.
- As of Q2 2021, Genmab A's EPS (Basic) stood at $1.99, which was up 110.72% from $0.94 recorded in Q4 2020.
- Over the past 5 years, Genmab A's EPS (Basic) peaked at $1.99 during Q2 2021, and registered a low of $0.13 during Q2 2019.
- Over the past 3 years, Genmab A's median EPS (Basic) value was $0.87 (recorded in 2019), while the average stood at $0.87.
- Data for Genmab A's EPS (Basic) shows a peak YoY spiked of 360.02% (in 2021) over the last 5 years.
- Genmab A's EPS (Basic) (Quarterly) stood at $0.32 in 2018, then soared by 169.94% to $0.87 in 2019, then increased by 8.37% to $0.94 in 2020, then spiked by 360.02% to $1.99 in 2021.
- Its EPS (Basic) stands at $1.99 for Q2 2021, versus $0.94 for Q4 2020 and $0.43 for Q2 2020.
